News
At Kennesaw State University’s X Lab, assistant professor of information technology Chloe Yixin Xie and sophomore computer ...
AI in Cancer Drug Discovery could prove paradigm shifting, but what challenges does it present? And how can they be avoided?
David Baker’s Nobel Prize-winning lab has generated AI-designed proteins to enhance the immune system's ability to detect and ...
In contrast to AI-driven drug discovery companies like Xaira, Recursion, or DeepMind spinout Isomorphic Labs, which focus on ...
Isomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope ...
Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...
Wayve was among the first unicorn AI startups in the UK, getting funding of over $1 billion for its self-driving artificial intelligence technology. The company is based in London and had its ...
Discover Grok 4, the AI model redefining advanced reasoning and problem-solving. Explore its potential, challenges, and ...
Below are the most-read DIGITIMES Asia stories from July 7 to July 13, 2025. This week's top three highlights include China’s ...
A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?
While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results